ライフサイエンスコーパス: Gram-negative

1 y urinary (29.2%), gastrointestinal (20.4%), Gram negative (29.9%), Gram positive (16.8%), and cultur

2 Two gram-negative anaerobic rod taxa, Prevotella and Porphyr

3 Antibacterial activity against model Gram negative and Gram positive bacteria is reported for

4 microbial susceptibility in a wider range of Gram negative and Gram positive bacteria.

5 hloramphenicol, and co-trimoxazole; 68.3% of Gram-negative and 6.6% of Gram-positive pathogens.

6 00 cells per run in a synthetic community of Gram-negative and Gram-positive bacteria and fungi.

7 et, the difference in mechanism of action on gram-negative and gram-positive bacteria may be less pro

8 ed on four bacterial strains, including both Gram-negative and Gram-positive bacteria, showing great

9 re associated with secretion systems in many Gram-negative and Gram-positive bacteria.

10 Vibrio vulnificus is a Gram-negative aquatic bacterium first isolated by the Un

11 Eighty Gram-negative bacilli (54 Enterobacteriaceae and 26 nonf

12 arbapenemase-producing glucose-nonfermenting Gram-negative bacilli (CPNFs), including Pseudomonas aer

13 Gram-negative bacilli (GNB) bacteremia is typically tran

14 tion being significantly shorter for enteric Gram-negative bacilli and enterococci (means, 3.6 h and

15 l stewardship in patients with less frequent Gram-negative bacilli bloodstream infections.

16 ce characteristics for the identification of Gram-negative bacilli commonly isolated from blood cultu

17 Infections due to resistant gram-negative bacilli continue to cause unacceptable mor

18 uter membrane, C10OOc12O was able to enhance gram-negative bacilli susceptibility to antibacterial co

19 peptides may therefore be useful in fighting gram-negative bacilli threats through sensitization to e

20 es to antibiotics, we attempted to sensitize gram-negative bacilli to innate antibacterial protagonis

21 A total of 210 Bactec bottles demonstrating Gram-negative bacilli were prospectively enrolled for th

22 (54 Enterobacteriaceae and 26 nonfermenting Gram-negative bacilli) obtained from multiple institutio

23 Gram-negative bacilli, Staphylococcus aureus, Chlamydia,

24 ., Northfield, IL) for the identification of Gram-negative bacilli.

25 Gram-negative bacteremia (GNB) is a major cause of illne

26 Currently, the management of gram-negative bacteremia is determined by clinical judgm

27 rains 0.3-8 mug/mL) than for the majority of Gram negative bacteria (Pseudomonas aeruginosa, 16-32 mu

28 um chemotaxis towards live gram positive and gram negative bacteria and demonstrate high sensitivity

29 e potentially useful biological functions in Gram negative bacteria.

30 s on the cell wall of both gram positive and gram negative bacteria.

31 e active against Gram positive bacteria than Gram negative bacteria; however zerumbone showed highest

32 Mechanisms of drug resistance in gram-negative bacteria (GNB) are numerous; beta-lactamas

33 Predicting antimicrobial resistance in gram-negative bacteria (GNB) could balance the need for

34 Gram-negative bacteria (GNBs) are common pathogens causi

35 es for the prevention of multidrug-resistant gram-negative bacteria (MDR-GNB) in adult intensive care

36 occus aureus and Streptococcus pyogenes) and gram-negative bacteria (Pseudomonas aeruginosa and Esche

37 togenes, Geobacillus stearothermophilus) and gram-negative bacteria (Pseudomonas aeruginosa, Pseudomo

38 ated molecular patterns in gram-positive and gram-negative bacteria activate IL-1beta release from im

39 urpose, we chose the pilus protein FimG from Gram-negative bacteria and a disulfide-bonded variant of

40 le to rapidly traverse the outer membrane of Gram-negative bacteria and accumulate inside these cells

41 acteria that are obligate predators of other Gram-negative bacteria and are considered potential alte

42 he periplasmic side of the inner membrane of Gram-negative bacteria and are then extracted by the Lpt

43 biofilm resistance to both Gram-positive and Gram-negative bacteria and fungi: it remains almost "zer

44 ed protein H-NS is a key global regulator in Gram-negative bacteria and is believed to be a crucial p

45 a six-component system that is widespread in Gram-negative bacteria and is thought to mediate retrogr

46 lass of molecules found in Gram-positive and Gram-negative bacteria and most archaea(1-5).

47 The hallmark of gram-negative bacteria and organelles such as mitochondr

48 line for pilus production at the surface of Gram-negative bacteria and the archetypical protein-poly

49 ericidal protein that limits contact between Gram-negative bacteria and the colonic epithelial surfac

50 iens, Viridiplantae, Gram-positive Bacteria, Gram-negative Bacteria and Virus .

51 Gram-negative bacteria are common in pneumonia and incre

52 udies have shown that conjugation systems of Gram-negative bacteria are composed of distinct inner an

53 Although a number of Gram-negative bacteria are known to catabolize quinate a

54 ling and export of amyloid protein sequences.Gram-negative bacteria assemble biofilms from amyloid fi

55 f the greatest threats to human health, with gram-negative bacteria being of major concern.

56 Mouse and human RELMbeta selectively killed Gram-negative bacteria by forming size-selective pores t

57 Bioinformatic screens reveal that these gram-negative bacteria carry genes coding for thiol-disu

58 90 bloodstream isolates of the 4 most common gram-negative bacteria causing bloodstream infections in

59 evalence of MCRPE infection from isolates of Gram-negative bacteria collected at the hospitals from 2

60 The cell surface of most Gram-negative bacteria contains lipopolysaccharide that

61 release (ER) in severe infections caused by gram-negative bacteria could be a matter of concern.

62 pime-tazobactam when tested against clinical Gram-negative bacteria during clinical studies and routi

63 nder a low light dose (0.6 J cm(-2) ) toward Gram-negative bacteria E. coli, making it a remarkably e

64 h TLR4, as well as through activation by the Gram-negative bacteria E. coli, results in reduced NET p

65 s and Enterococcus faecalis, and against the Gram-negative bacteria Escherichia coli, Escherichia col

66 y that targets a highly conserved protein of Gram-negative bacteria essential for the fitness of V. c

67 anism of inter-cellular competition in which Gram-negative bacteria exchange polymorphic toxins using

68 Gram-negative bacteria express a diverse array of lipopr

69 of any known membrane-embedded insertase in Gram-negative bacteria fold into a prepore before membra

70 , III, IV, and VI), which are widely used by Gram-negative bacteria for pathogenesis.

71 bat multidrug resistant bacteria, especially Gram-negative bacteria for which the situation is partic

72 will be the effectiveness of EDP on reducing Gram-negative bacteria growth and the opposite trend was

73 Multidrug-resistant (MDR) gram-negative bacteria have increased the prevalence of

74 ed to invade, reseal, kill, and digest other gram-negative bacteria in soils and water environments.

75 AMP responses against both Gram-positive and Gram-negative bacteria in T. molitor.

76 he biosensor construct was tested in several Gram-negative bacteria including Pseudomonas, Shewanella

77 an effective permeability barrier that makes Gram-negative bacteria inherently resistant to many anti

78 machines used for injection of proteins from Gram-negative bacteria into eukaryotic cells.

79 genesis of outer-membrane proteins (OMPs) in gram-negative bacteria involves delivery by periplasmic

80 The outer membrane (OM) of Gram-negative bacteria is a permeability barrier and an

81 eactivity to antigens from Gram-positive and Gram-negative bacteria is common in patients suffering f

82 The Cu tolerance system in Gram-negative bacteria is composed minimally of a Cu sen

83 The outer membrane (OM) of Gram-negative bacteria is composed of lipopolysaccharide

84 olysaccharide (LPS) in the outer membrane of Gram-negative bacteria is critical for the assembly of t

85 Antimicrobial resistance in pathogenic gram-negative bacteria is one of the most pressing chall

86 he mechanism of action of promysalin against Gram-negative bacteria is still not clarified, even if a

87 Activation of TLR4 by Gram-negative bacteria or lipopolysaccharide accelerates

88 Gram-negative bacteria possess specialised biogenesis ma

89 lex (Bcc) are a group of multidrug-resistant gram-negative bacteria rarely reported in patients witho

90 Gram-negative bacteria remodel their surfaces to interac

91 ctivity against a panel of Gram-positive and Gram-negative bacteria revealed structure-activity relat

92 Gram-negative bacteria secrete proteins using a type III

93 represent a major mechanism of resistance in Gram-negative bacteria showing multi-drug or extensively

94 Gram-negative bacteria such as Escherichia coli are prot

95 c children, nasopharyngeal colonization with Gram-negative bacteria such as Haemophilus influenzae an

96 Images of gram-positive and gram-negative bacteria taken with this technique show ex

97 Lipopolysaccharide (LPS) is the component of Gram-negative bacteria that activates Toll-like receptor

98 Brucella spp. are facultative intracellular Gram-negative bacteria that cause the zoonotic disease b

99 imeric channels across the outer membrane of Gram-negative bacteria that mediate the import or export

100 Proteins (PGRPs) kill both Gram-positive and Gram-negative bacteria through simultaneous induction of

101 complexes constitute a primary mechanism for Gram-negative bacteria to expel toxic molecules for surv

102 and utilization of enterobactin permits many Gram-negative bacteria to thrive in environments where l

103 acter baumannii is one of the most difficult Gram-negative bacteria to treat and eradicate.

104 an discriminate between viable and nonviable Gram-negative bacteria to tune the immune response, ther

105 Many pathogenic Gram-negative bacteria use the type III secretion system

106 Many Gram-negative bacteria use type 2 secretion systems (T2S

107 omysalin is active against Gram-positive and Gram-negative bacteria using a microdilution assay.

108 Colonization by resistant gram-negative bacteria was significantly associated with

109 sceptibility profiles of clinically relevant Gram-negative bacteria within two hours of antibiotic in

110 The cell envelope of gram-negative bacteria, a structure comprising an outer

111 io aeruginosavorus are obligate predators of Gram-negative bacteria, and have been proposed to be use

112 enable gene exchange between five species of Gram-negative bacteria, and that the identity of the gen

113 acellular sensors for both Gram-positive and Gram-negative bacteria, but their role in steady-state h

114 In Gram-negative bacteria, efflux pumps are able to prevent

115 HFM and showed that HFM increases rat fecal Gram-negative bacteria, elevates lipopolysaccharides (LP

116 espread antibiotic resistance, especially of Gram-negative bacteria, has become a severe concern for

117 id development of resistance particularly in Gram-negative bacteria, illustrates the urgent need for

118 it is widespread in more than 25 species of Gram-negative bacteria, including enterohemorrhagic E. c

119 In many Gram-negative bacteria, including Rhodobacter capsulatus

120 These Gram-negative bacteria, including the species Vibrio vul

121 The zauPzapA operon is present in diverse Gram-negative bacteria, indicating a common mechanism fo

122 In Gram-negative bacteria, lipid modification of proteins i

123 multitude of essential cellular functions in Gram-negative bacteria, mitochondria and chloroplasts.

124 The T6SS is widespread among Gram-negative bacteria, mostly within the Proteobacteriu

125 n across the cell envelope are widespread in Gram-negative bacteria, NBs are found exclusively in gam

126 In Gram-negative bacteria, outer membrane phospholipase A (

127 ride (LPS), which is a membrane component of gram-negative bacteria, secrete more EVs than cholangioc

128 In Gram-negative bacteria, some of these pumps form multi-p

129 light that, although BAM is conserved across Gram-negative bacteria, structural and functional differ

130 In many Gram-negative bacteria, the peptidoglycan synthase PBP1A

131 le for detecting lipopolysaccharide (LPS) of Gram-negative bacteria, was immobilized on both a large

132 ted excellent sensitivity to trace levels of Gram-negative bacteria, while remaining insensitive to b

133 is markedly induced by avirulent strains of Gram-negative bacteria, Yersinia and Klebsiella, and les

134 sidues that occurs in most Gram-positive and Gram-negative bacteria.

135 anders are multifaceted infections caused by gram-negative bacteria.

136 mbrane has long defined the cell envelope of Gram-negative bacteria.

137 with the virulence of medically significant Gram-negative bacteria.

138 fections caused by multidrug-resistant (MDR) Gram-negative bacteria.

139 iaminopimelic-type peptidoglycans present in Gram-negative bacteria.

140 communication within and between species of Gram-negative bacteria.

141 LPS biosynthesis, transport, and assembly in Gram-negative bacteria.

142 idal activity against both Gram-positive and Gram-negative bacteria.

143 ity of specific Gram-positive antibiotics to Gram-negative bacteria.

144 and TonB-dependent transporters (TBDT) from Gram-negative bacteria.

145 both bacterial lipopolysaccharide (LPS) and gram-negative bacteria.

146 il microbial biomass, primarily by fungi and Gram-negative bacteria.

147 overy and development of antibiotics against Gram-negative bacteria.

148 isms of action of Ctn and Ctn(15-34) against Gram-negative bacteria.

149 lated inhibitor of DsbB enzymes from several Gram-negative bacteria.

150 similar to the HJ migration helicase RuvB in Gram-negative bacteria.

151 e bacterial cell surface was demonstrated in Gram-negative bacteria.

152 against multidrug-resistant tuberculosis and Gram-negative bacteria.

153 ride (LPS) constituting the outer leaflet of Gram-negative bacteria.

154 for developing countermeasures in pathogenic Gram-negative bacteria.

155 ed from work with Escherichia coli and other Gram-negative bacteria.

156 essential outer membrane glycolipids in most gram-negative bacteria.

157 nserved cell-cell communication mechanism in Gram-negative bacteria.

158 ycobacteria, and anaerobic Gram-positive and Gram-negative bacteria.

159 change of acyl-homoserine lactones (AHLs) by Gram-negative bacteria.

160 (LPS), the major outer-membrane component of Gram-negative bacteria.

161 ne" antibiotic against extensively-resistant Gram-negative bacteria.

162 t commensal and pathogenic Gram-positive and Gram-negative bacteria.

163 her MDR pathogens, such as malaria, HIV, and Gram-negative bacteria.

164 upies the space between the two membranes of Gram-negative bacteria.

165 purposing candidate to treat infections with Gram-negative bacteria.

166 otein in the extracellular matrix of enteric Gram-negative bacteria.

167 eta-barrel outer membrane proteins (OMPs) in Gram-negative bacteria.

168 tic cell-cell interactions between competing Gram-negative bacteria.

169 rel proteins into the outer membrane (OM) of Gram-negative bacteria.

170 t clinical needs in treating infections with Gram-negative bacteria.

171 are also relevant for other T3SS-containing Gram-negative bacteria.

172 e role of Type Vd secreted phospholipases in Gram-negative bacteria.

173 domains are widespread in toxins that target Gram-negative bacteria.

174 g highly effective against Gram-positive and Gram-negative bacteria; and (iii) the concentration of t

175 imics the structural moieties of its natural Gram negative bacterial pathogen-associated molecular pa

176 s and show that constriction in a variety of Gram-negative bacterial cells, including Proteus mirabil

177 Gram-negative bacterial endotoxin lipopolysaccharide (LP

178 nflammasome-based surveillance machinery for Gram-negative bacterial infections has been recently dis

179 In Drosophila the Imd pathway detects Gram-negative bacterial infections through recognition o

180 gram-positive bacterial isolates (57.9%), 17 gram-negative bacterial isolates (22.4%), and 15 fungal

181 The Gram-negative bacterial outer membrane (OM) is a unique

182 component of LPS in the outer leaflet of the Gram-negative bacterial outer membrane.

183 Pseudomonas aeruginosa is a Gram-negative bacterial pathogen associated with acute a

184 Tularemia is caused by the Gram-negative bacterial pathogen Francisella tularensis

185 enterica serovar Typhi is a human-restricted Gram-negative bacterial pathogen responsible for causing

186 ss termed "effector-triggered immunity." The Gram-negative bacterial pathogen Yersinia inactivates cr

187 response of Sts(-/-) mice to infection by a Gram-negative bacterial pathogen.

188 Many Gram-negative bacterial pathogens use a syringe-like app

189 Gram-negative bacterial pathogens utilize virulence-asso

190 locks into the backbone of Gram-positive and Gram-negative bacterial PG utilizing metabolic cell wall

191 ibility profiling for both Gram-positive and Gram-negative bacterial species requires at least 48-72

192 pe 6 secretion system (T6SS) is used by many Gram-negative bacterial species to deliver toxic effecto

193 e III and type IV effector proteins from six Gram-negative bacterial species to interact with the euk

194 ncludes well-characterized gram-positive and gram-negative bacterial strains published by ARLG invest

195 riose was taken up in both gram-positive and gram-negative bacterial strains.

196 needle-tip invasin proteins SipD and IpaD of Gram-negative bacterial type-3 secretion systems that br

197 The Gram-negative bacterium Bordetella pertussis is the caus

198 de to understand morphology in the dimorphic Gram-negative bacterium Caulobacter crescentus.

199 ions with model biological membranes and the Gram-negative bacterium Shewanella oneidensis MR-1.

200 Granulibacter bethesdensis is a Gram-negative bacterium that infects patients with chron

201 arainfluenzae is a nutritionally fastidious, Gram-negative bacterium with an oropharyngeal/nasopharyn

202 This method was successfully applied to a Gram-negative bacterium; it has yet to be implemented in

203 Predominant Gram-negative baseline pathogens in the microbiologicall

204 The Gram-negative Bdellovibrio bacteriovorus (BV) is a model

205 tudies support a uniquely nuanced pathway of Gram-negative CAMPs resistance and provide a more detail

206 However, recent evidence points towards a Gram-negative cell plan for Planctomycetes, although in-

207 ns and proteomic analyses support an altered Gram-negative cell plan for Planctomycetes, including a

208 Aggregatibacter actinomycetemcomitans is a Gram-negative commensal bacterium of the oral cavity whi

209 The mission of the Gram-Negative Committee is to advance our knowledge of t

210 eins retaining functions similar to those in Gram-negative counterparts.

211 ro susceptibilities, inappropriate (initial) gram-negative coverage was given in 9 of 245 (4%) and 18

212 tial distribution of the main colonizer, the Gram-negative Curvibacter sp., along the body axis.

213 Neisseria meningitidis (Nm) is a Gram-negative diplococcus that normally colonizes the na

214 lling efficiency toward both B. subtilis and Gram negative E. coli, features that demonstrate the pro

215 CD/linalool-IC-NFs inhibited growth of model Gram-negative (E. coli) and Gram-positive (S. aureus) ba

216 in vitro susceptibility of Gram-positive and Gram-negative endophthalmitis bacterial isolates to vanc

217 and the crystal structure of a PRF from the Gram-negative endophytic bacterium Burkholderia phytofir

218 The Gram-negative entomopathogenic bacterium Photorhabdus lu

219 the gastric pathogen Helicobacter pylori, a Gram-negative epsilonproteobacterium, encodes two protei

220 Mixed Gram-negative flora, suggesting fecal contamination was,

221 nce with previously identified DSDs from the Gram-negative genus, Acinetobacter, but instead shows li

222 Gram-positive (other-GP) bacteria (7.4%) and Gram-negative (GN) bacteria (7.1%).

223 vitro activity against clinically important gram-negative, gram-positive aerobic, and facultative ba

224 gardless of the inciting bacterial stimulus (gram-negative, gram-positive, or bacterial products).

225 of antimicrobial resistance, particularly in Gram-negative hospital pathogens, which has led to renew

226 TTOT (48.21 versus 11.75 h; P < 0.001), the Gram-negative infection (GNI) TTOT (71.83 versus 35.98 h

227 ovel antibiotics to treat drug-resistant and Gram-negative infections.

228 pment of novel therapeutic options to manage Gram-negative infections.

229 cal development for the treatment of serious Gram-negative infections.

230 The outer membrane (OM) of Gram-negative is a unique lipid bilayer containing LPS i

231 Pseudomonas aeruginosa MexAB-OprM pump in a Gram-negative membrane model that contained both inner a

232 EVs were harvested from three species of Gram-negative microbes carrying different plasmids.

233 Depletion of Gram-negative microbiota, hematopoietic cell deletion of

234 Here, we have addressed this question in the Gram-negative model bacterium Burkholderia thailandensis

235 Twenty-one small Gram-negative motile coccobacilli were isolated from 15

236 teriaceae isolates, 5 Gram-positive cocci, 5 Gram-negative nonfermenting species, 9 Mycobacterium tub

237 f the Burkholderia cepacia complex (Bcc) are Gram-negative opportunisitic bacteria that are capable o

238 Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that requires iron

239 is a potent phospholipase A2 secreted by the Gram-negative opportunistic pathogen, Pseudomonas aerugi

240 Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen that infects immun

241 vided into two groups by their hosts, either Gram-negative or Gram-positive bacteria.

242 Emerging evidence also indicates that gram-negative oral bacteria, such as Porphyromonas gingi

243 Pseudomonas aeruginosa is a pathogenic gram-negative organism that has the ability to cause bli

244 ram-positive (OR, 0.73; 95% CI, .55-.97) and gram-negative organisms (0.51; .33-.78) but not yeast (0

245 ms predominate, whereas later more resistant Gram-negative organisms are found.

246 ens, novobiocin has limited activity against Gram-negative organisms due to the presence of the lipop

247 Among neonates, Gram-negative organisms were the predominant cause of ea

248 e report that GA is antibacterial, targeting Gram-negative organisms with higher activity towards Pse

249 The nefarious Gram-negative pathogen Pseudomonas aeruginosa encodes el

250 The Gram-negative pathogen Pseudomonas aeruginosa has three

251 Here we demonstrate that the Gram-negative pathogen Pseudomonas aeruginosa is suscept

252 Vibrio cholerae is a Gram-negative pathogen that can use its T6SS during anta

253 icle considers the cases of the non-invasive Gram-negative pathogen Vibrio cholerae and the invasive

254 he preferential selectivity of the method is gram negative pathogenic species E. coli O157:H7.

255 hyllococcus aureus and Enterococcus) and two gram negative pathogens (E. coli and Salmonella).

256 cterial activities against Gram-positive and Gram-negative pathogens (Staphylococcus aureus, Enteroba

257 CDI systems are distributed widely among Gram-negative pathogens and are thought to mediate inter

258 vel E3 ligase (NEL) domain that is unique to Gram-negative pathogens and whose activity is repressed

259 bacterial clearance in, animal models of the Gram-negative pathogens Haemophilus influenzae and Neiss

260 Numerous Gram-negative pathogens infect eukaryotes and use the ty

261 ype II secretion (T2S) is one means by which Gram-negative pathogens secrete proteins into the extrac

262 bapenemase-producing organisms, or CPOs, are Gram-negative pathogens that produce a transmissible car

263 d apparatus functions in the injectisomes of gram-negative pathogens to export virulence factors into

264 and fluoroquinolone resistance among common Gram-negative pathogens, and the emergence of MRSA, high

265 e of the major contributors to resistance in Gram-negative pathogens, by efficiently expelling a broa

266 on (T3S), a protein export pathway common to Gram-negative pathogens, comprises a trans-envelope syri

267 rio bacteriovorus bacteria naturally prey on Gram-negative pathogens, including antibiotic-resistant

268 r process that occurs in the injectisomes of gram-negative pathogens, is termed type-III secretion.

269 class of molecules toward difficult-to-treat Gram-negative pathogens.

270 e- and multidrug-resistant Gram-positive and Gram-negative pathogens.

271 beta-lactam activity in a broad range of MDR Gram-negative pathogens.

272 inst a diverse panel of multi-drug-resistant Gram-negative pathogens.

273 g ventilator-associated pneumonia) caused by Gram-negative pathogens.

274 at are active against both Gram-positive and Gram-negative pathogens.

275 of inter-bacterial competition found in many Gram-negative pathogens.

276 only associated with antimicrobial-resistant Gram-negative pathogens.

277 cterial activity, including activity against Gram-negative pathogens.

278 LyeTxI/betaCD was determined for planktonic Gram-negative periodontopathogens.

279 ival of microbiota members from the dominant Gram-negative phylum Bacteroidetes depends on their abil

280 of broad-spectrum compounds transcending the Gram negative-positive borderline.

281 g, modifying and finally destroying walls of Gram-negative prey bacteria, modifying their own PG as t

282 lipopolysaccharide, a cell wall component of Gram-negative Proteobacteria and known inducer of lupus

283 eriovorus and Micavibrio aeruginosavorus are Gram-negative proteobacteria that are obligate predators

284 ons: gram-positive Staphylococcus aureus and gram-negative Pseudomonas aeruginosa (99.3 +/- 1.9% and

285 rom both Gram-positive Bacillus subtilis and Gram-negative Pseudomonas aeruginosa.

286 ic Gram-positive rods and other uncultivable Gram-negative rods, and, rarely, opportunistic microorga

287 at recurrent nonlethal gastric infections of Gram-negative Salmonella enterica Typhimurium (ST), a ma

288 NAs in monocytes isolated from patients with Gram-negative sepsis compared with healthy control subje

289 endent Ags, and they are more susceptible to Gram-negative sepsis.

290 ression as a key modulator of mortality from Gram-negative sepsis.

291 A total of 78 clinical isolates of 13 Gram-negative species collected between April 2013 and N

292 e a number of clinical isolates of important Gram-negative species-Enterobacter cloacae, Escherichia

293 multidrug resistant (MDR) Gram-positive and Gram-negative species.

294 s composed of 15 conserved proteins in model gram-negative species.

295 r consideration as a vaccine target for some Gram-negative species.

296 orter that is expressed in gram-positive and gram-negative strains of bacteria.

297 13 showed moderate activity against the MDR Gram-negative strains, with MICs in the range of 16-32 m

298 This Gram-negative system bears striking resemblance to a rel

299 al NADases predicted to transit not only the Gram-negative T6SS but also the Gram-positive type VII s

300 Six gram-negative waterborne pathogens were used to demonstr